Mexican Patent Office grants patent for compounds treating viral infections

Godavari Biorefineries has informed the exchanges that the Mexican Patent Office has granted its patent application.

Fri 2 Oct 2026

Patent Title

USE OF COMPOUNDS FOR TREATING VIRAL INFECTIONS

Granting Authority

Mexican Patent Office

Patent Term

20 years

What the company informed the exchanges

Godavari Biorefineries has informed the National Stock Exchange of India Limited and BSE Limited that the Mexican Patent Office has granted its patent application titled "USE OF COMPOUNDS FOR TREATING VIRAL INFECTIONS."

The company states that the invention relates to the use of compounds for inhibiting V-ATPase activity in cells, and further discloses their use in the manufacture of medicaments for the treatment of viral infections.

Details from the grant certificate

• Title: USE OF COMPOUNDS FOR TREATING VIRAL INFECTIONS (Spanish: USO DE COMPUESTOS PARA EL TRATAMIENTO DE INFECCIONES VIRALES)
• Patent number: 438818
• Holder: Godavari Biorefineries Limited
• Named inventors: Athavale, Maithili; Gavade, Sandip; Kharkar, Prashant; Srivastava, Sangeeta
• International update date: 10 May 2021
• Priority date: 11 May 2020, priority country IN
• Grant (expedition) date: 15 September 2026
• Validity: 20 years
• Expiry date: 10 May 2041

What a patent grant means

A granted patent is a legal right over the claimed invention in the country that grants it, for the term of the patent. In this case the Mexican Patent Office has granted the application covering the use of these compounds and their use in making medicaments for viral infections.

The company has shared this as a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and describes it as being for information and records.

How an investor might read it

• The grant adds a patent to the company's intellectual property covering use of these compounds in treating viral infections.
• The rights covered are those granted by the Mexican Patent Office for the term stated on the certificate.
• Investors typically track such grants as milestones in a company's research and intellectual-property work.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.